Key result
Intracoronary γ-radiation therapy with (192)Ir reduced the decrease in stented segment lumen volume compared to placebo.
Why the study?
Does intracoronary gamma-radiation therapy reduce recurrent in-stent restenosis in patients after successful reintervention?
RCT (n=70)
randomized
Does intracoronary gamma-radiation therapy reduce recurrent in-stent restenosis in patients after successful reintervention?
Intracoronary gamma-radiation therapy effectively inhibits neointimal formation and prevents recurrent in-stent restenosis as assessed by serial volumetric IVUS.
Answers are grounded in this paper and cite their sources.
Supports γ-radiation after reintervention for in-stent restenosis; confirms neointimal inhibition in RCT.
BACKGROUND: The aim of this study was to use serial volumetric intravascular ultrasound to evaluate the effect of gamma-radiation on recurrent in-stent restenosis. METHODS AND RESULTS: After successful reintervention, patients were randomized to receive either (192)Ir or placebo. Intravascular ultrasound studies with motorized pullback (0.5 mm/s) were performed immediately after irradiation and at 8-month follow-up in 70 patients. Paired volumetric analysis of the stented segment and of 5-mm proximal and distal reference segments was performed; this included measurements of the external elastic membrane, lumen, plaque and media (external elastic membrane minus lumen), stent, and intimal hyperplasia (stent minus lumen). Baseline proximal reference, stent, and distal reference measurements were similar in both groups. The changes in proximal and distal reference measurements of the external elastic membrane, plaque and media, and lumen areas were similar in both groups. However, the decrease in stented segment lumen volume was less in the (192)Ir patients than the placebo patients (-25+/-34 mm(3) versus -48+/-42 mm(3); P:=0.0225), and the increase in the volume of intimal hyperplasia in the stented segment was less in the (192)Ir patients than in the placebo patients (28+/-37 mm(3) versus 50+/-40 mm(3); P:=0.0352). When averaged over the length of the stented segment (32+/-13 mm versus 33+/-14 mm; P:=0.9), the increase in mean area of intimal hyperplasia was 0.8+/-1.0 mm(2) in the (192)Ir group and 1.6+/-1.2 mm(2) in the control group (P:=0.0065). Late stent-vessel wall malapposition was noted in one placebo patient and no (192)Ir patients. CONCLUSIONS: gamma-Radiation therapy can effectively prevent recurrent in-stent restenosis by inhibiting neointimal formation within the stent. At the stent edge, there were no significant differences between (192)Ir and placebo patients.
No takes yet. Share an insight, caveat, or question.
Mintz et al. (2000) conducted an RCT in In-stent restenosis (n=70). Intracoronary γ-Radiation Therapy ((192)Ir) vs. Placebo was evaluated on Decrease in stented segment lumen volume (p=0.0225). Intracoronary γ-radiation therapy with (192)Ir reduced the decrease in stented segment lumen volume compared to placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: